רבוקסטין (Hebrew Wikipedia)

Analysis of information sources in references of the Wikipedia article "רבוקסטין" in Hebrew language version.

refsWebsite

Global rank Hebrew rank

5doi.org

2^nd place

10^th place

4nih.gov

4^th place

18^th place

1wiley.com

222^nd place

106^th place

1science.org

1,160^th place

787^th place

doi.org

dx.doi.org

Dirk Eyding, Monika Lelgemann, Ulrich Grouven, Martin Härter, Mandy Kromp, Thomas Kaiser, Michaela F. Kerekes, Martin Gerken, Beate Wieseler, Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials, BMJ (Clinical research ed.) 341, 2010-10-12, עמ' c4737 doi: 10.1136/bmj.c4737
Andrea Cipriani, Toshiaki A. Furukawa, Georgia Salanti, John R. Geddes, Julian Pt Higgins, Rachel Churchill, Norio Watanabe, Atsuo Nakagawa, Ichiro M. Omori, Hugh McGuire, Michele Tansella, Corrado Barbui, Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis, Lancet (London, England) 373, 2009-02-28, עמ' 746–758 doi: 10.1016/S0140-6736(09)60046-5
P. Melloni, G. Carniel, A. Della Torre, A. Bonsignori, M. Buonamici, O. Pozzi, S. Ricciardi, A. C. Rossi, ChemInform Abstract: POTENTIAL ANTIDEPRESSANT AGENTS. α-ARYLOXY-BENZYL DERIVATIVES OF ETHANOLAMINE AND MORPHOLINE, Chemischer Informationsdienst 15, 1984-10-30 doi: 10.1002/chin.198444244
G. Cocchiara, R. Battaglia, P. Pevarello, M. Strolin Benedetti, Comparison of the disposition and of the metabolic pattern of Reboxetine, a new antidepressant, in the rat, dog, monkey and man, European Journal of Drug Metabolism and Pharmacokinetics 16, 1991, עמ' 231–239 doi: 10.1007/BF03189965
Michelle E. Page, The promises and pitfalls of reboxetine, CNS drug reviews 9, 2003, עמ' 327–342 doi: 10.1111/j.1527-3458.2003.tb00258.x

nih.gov

pubmed.ncbi.nlm.nih.gov

Dirk Eyding, Monika Lelgemann, Ulrich Grouven, Martin Härter, Mandy Kromp, Thomas Kaiser, Michaela F. Kerekes, Martin Gerken, Beate Wieseler, Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials, BMJ (Clinical research ed.) 341, 2010-10-12, עמ' c4737 doi: 10.1136/bmj.c4737
Andrea Cipriani, Toshiaki A. Furukawa, Georgia Salanti, John R. Geddes, Julian Pt Higgins, Rachel Churchill, Norio Watanabe, Atsuo Nakagawa, Ichiro M. Omori, Hugh McGuire, Michele Tansella, Corrado Barbui, Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis, Lancet (London, England) 373, 2009-02-28, עמ' 746–758 doi: 10.1016/S0140-6736(09)60046-5
G. Cocchiara, R. Battaglia, P. Pevarello, M. Strolin Benedetti, Comparison of the disposition and of the metabolic pattern of Reboxetine, a new antidepressant, in the rat, dog, monkey and man, European Journal of Drug Metabolism and Pharmacokinetics 16, 1991, עמ' 231–239 doi: 10.1007/BF03189965
Michelle E. Page, The promises and pitfalls of reboxetine, CNS drug reviews 9, 2003, עמ' 327–342 doi: 10.1111/j.1527-3458.2003.tb00258.x

science.org

Derek Lowe, Reboxetine Doesn't Work. But That's Not the Real Problem., www.science.org, ‏17/01/2011 (באנגלית)

wiley.com

onlinelibrary.wiley.com

P. Melloni, G. Carniel, A. Della Torre, A. Bonsignori, M. Buonamici, O. Pozzi, S. Ricciardi, A. C. Rossi, ChemInform Abstract: POTENTIAL ANTIDEPRESSANT AGENTS. α-ARYLOXY-BENZYL DERIVATIVES OF ETHANOLAMINE AND MORPHOLINE, Chemischer Informationsdienst 15, 1984-10-30 doi: 10.1002/chin.198444244